thursday, october 2, 2014 08:30 09:45 state of … · 2014-09-26 · level 2 coronary artery...

THURSDAY, OCTOBER 2, 2014 08:30 – 09:45 STATE OF THE ART LECTURES 1 ROOM 1

Level 2 Coronary artery disease: Integrating cardiac CT and cardiac MR into clinical practice Chair: P. Gueret, Creteil/FR Ch. Loewe, Vienna/AT 08:30 101 Is there a role of CTA in patients with known CAD? F. Pugliese, London/UK

08:44 102 CTA in the impact of management of patients presenting acute chest pain M. Sirol, Paris/FR 09:00 103 Cardiac MR in patients with chest pain, raised troponin and unobstructive

coronary arteries H. Marques, Lison/PT

09:15 104 What have we learned from cardiac CT registry and meta analysis?

M. Dewey, Berlin/DE

09:30 Discussion

08:30 – 09:45 PROFFERED PAPER SESSION 1 ROOM 2

Myocardial characterisation Chair: F. Bamberg, Tuebingen/DE

D. Revel, Lyon/FR 08:30 105 T1-, T2-mapping and extracellular volume quantification for the diagnosis of

subclinical acute cellular rejection in patients after heart transplantation using 1.5 tesla CMR L. Hildebrand, Leipzig/DE

08:40 106 Determination of myocardial triglyceride content in patients with fabry

disease. A 3T 1H-magnetic resonance spectroscopy study B. Petritsch, Wuerzburg/DE

08:50 107 Multidetector-computed tomography (MDCT) with late-enhancement and

electroanatomic mapping (EAM) in patients affected by ventricular tachycardia (VT): A point-by-point correlation

C. Colantoni, Milan/IT 09:00 108 Cardiac enzyme peaks at admission could predict presence of microvascular

obstruction at cardiac magnetic resonance after acute myocardial infarction A. Damascelli, Milan/IT

09:10 109 Impact of intramyocardial hemorrhage on LV remodeling in reperfused

acute myocardial infarction M. Sirol, Paris/FR 09:20 110 Age dependency of myocardial triglyceride content - A 3T high-field 1H-

magnetic resonance spectroscopy study T. Gassenmaier, Wuerzburg/DE 09:30 111 Systematic evaluation of three different cardiac T2-mapping sequences at

1.5 and 3T in healthy volunteers B. Baessler, Cologne/DE

08:30 – 09:45 REFRESHER COURSE 1 ROOM 3

Level 2 Imaging of the left atrium and atrial fibrillation Chair: G. Feuchtner, Innsbruck/AT M. Rees, Gwynedd/UK 08:30 112 The role of echocardiography

M. Rees, Gwynedd/UK

08:45 113 Anatomy and function of the left atrium by either CT or cardiac MR L. Macron, Paris/FR 09:00 114 CT and atrial fibrillation G. Feuchtner, Innsbruck/AT 09:15 115 Cardiac MR and atrial fibrillation H. Cochet, Pessac/FR 09:30 Discussion 10:00 – 11:30 OPENING SESSION ROOM 1

Level 2 Cardiac imaging in CAD: From recent guidelines to next future Chair: Ch. Loewe, Vienna/AT

V. Sinitsyn, Moscow/RU 10:00 116 Introductory speech E. Mousseaux, Paris/FR V. Sinitsyn, Moscow/RU 10:20 117 Guidelines: The current role of cardiac imaging N. Danchin, Paris/FR 10:40 118 Is it necessary to detect ischemia in stable subjects?

Ph.G. Steg, Paris/FR

11:00 119 Why cardiac CT and MR will weigh so much in the next future? M. Gutberlet, Leipzig/DE 11:20 Discussion 10:00 – 11:30 STATE OF THE ART LECTURES 2 ROOM 2

Level 3 Post processing in cardiac imaging Chair: N. Kachenoura, Paris/FR P. van Ooijen, Groningen/NL

10:00 120 Regional function by cardiac MR tagging P. Clarysse, Lyon/FR 10:15 121 Myocardial tracking for strain estimation in cardiac MR N. Kachenoura, Paris/FR 10:30 122 Myocardial Diffusion: From science to clinical applications Ch. Mekkaoui, Nimes/FR 10:45 123 Automated quantitative coronary artery stenosis in CT A. Broersen, Leiden/NL 11:00 124 Integration of electrophysiology and imaging for patient-specific models

and intervention planning M. Sermesant, Sophia Antipolis/FR

11:20 Discussion


Level 1-2 Pericardial diseases Chair: I. Bogaert, Leuven/BE P. Gueret, Creteil/FR 10:00 125 Clinical presentations and physiopathology of pericardial diseases P. Gueret, Creteil/FR 10:20 126 The role of CT/MR in effusive pericarditis R. Rienmueller, Graz/AT 10:40 127 Constrictive pericarditis: CT or cardiac MR? Ch. Peebles, Southampton/UK 11:15 Discussion

11:45 - 12:45 INDUSTRY-SPONSORED SYMPOSIUM ROOM 1

State of the art of cardiac CT imaging Chair: J.F. Paul, Paris/FR 11:45 Coronary subtraction - Improving evaluation of calcified coronary arteries in

CT A. Hidalgo, Barcelona/ES 12:05 Ultra low dose CTA - How low can you go O. Ghekiere, Liege/BE 12:25 Myocardial perfusion in clinical practice

J. Linde, Copenhagen/DK

13:00 - 14:15 STATE OF THE ART LECTURES 3 ROOM 1

Level 2 TAVI, principles and imaging requirements Chair: M. Gutberlet, Leipzig/DE G. Feuchtner, Innsbruck/AT 13:00 128 Principles and results of TAVI M. Gilard, Brest/FR 13:15 129 The role of echocardiography in transcatheter aortic valve implantation E. Brochet, Paris/FR 13:30 130 The role of CT before the procedure J.N. Dacher, Rouen/FR 13:45 131 Imaging in the follow up R. Salgado, Edegem/BE 14:00 Discussion

13:00 – 14:15 ESCR MEETS EuroCMR ROOM 2

Level 3 Myocardial characterisation of fibrosis by cardiac MR: State of the art Chair: P. Croisille, Lyon/FR

S. Plein, Leeds/UK 13:00 132 Late gadolinium-enhancement: Methods, quantification and limits U. Kramer, Tuebingen/DE

13:15 133 T1 Mapping: Techniques, variants, and derived biomarkers: Which are the good ones?

M. Viallon, Lyon/FR 13:30 134 T1 mapping: Normal values of native T1 and post-Gd T1: What is published? J. Moon, London/UK 13:45 135 Imaging of fibrosis: Current and future applications D. Messroghli, Berlin/DE 14:00 Discussion 13:00 – 14:15 REFRESHER COURSE 3 ROOM 3

Level 1-2 How to correctly set up a cardiac CT scan Chair: K. Nikolaou, Munich/DE

J.L. Sablayrolles, Saint Denis/FR

13:00 136 Coronary CTA protocols depending on objective and dose reduction S. Willoteaux, Angers/FR 13:15 137 Basic post-processing in CT J.L. Sablayrolles, Saint Denis/FR 13:30 138 The good cardiac CT report I. Mastorakou, Athens/GR 13:45 139 Cardiac CT in difficult patients (arrhythmia, calcification, obesity ...) A. Esposito, Milan/IT 14:00 Discussion 14:30 - 15:45 HIGHLIGHTED LECTURES 1 ROOM 1

Level 3 Should we combine coronary anatomy and perfusion in CT an MR? Chair: L. Natale, Rome/IT A. Redheuil, Paris/FR 14:30 140 Limitation of the anatomic approach by CTA J.N. Dacher, Rouen/FR 14:45 141 What is the added value of myocardial perfusion in CT? F. Bamberg, Tuebingen/DE 15:00 142 Results of cardiac MR in myocardial perfusion without coronary angiography J. Schwitter, Lausanne/CH 15:15 143 Is it necessary to add MR coronary angiography to cardiac MR perfusion? S. Plein, Leeds/UK 15:30 Discussion 14:30 – 15:45 PROFFERED PAPER SESSION 2 ROOM 2

Cardiac chamber function and morphology Chair: J. Bogaert, Leuven/BE J. Pontone, Milan/IT 14:30 144 Study of atrio-ventricular coupling in patients with transposition of the

great arteries after atrial switch using phase contrast cardiac magnetic resonance imaging

M. Ladouceur, Paris/FR

14:40 145 Differential effect of ratio of right ventricular volume to left ventricular volume in children with repaired tetralogy of fallot

X. Hu, Shanghai/CN 14:50 146 Performance of multislice CT in detecting prosthetic valve and device

dysfunction: Comparative study with echocardiography and surgery F. Plank, Innsbruck/AT 15:00 147 Accuracy of cardiac MRI single breath-hold vs. Non-breath-hold compressed

sensing input data for left ventricular volumetry: A clinical feasibility study S. Sudarski, Mannheim/DE

15:10 148 Assessment of aortic annulus dimensions for planning of transcatheter

aortic valve replacement (TAVR): Comparison of a non-contrast 3D-FLASH based MRI protocol at 3 T with contrast

Ph. Ruile, Bad Krozingen/DE 15:20 149 The size of the implanted prosthetic heart valve can accurately and non-

invasively be determined by multidetector-row computed tomography D. Sucha, Utrecht/NL 15:30 150 Percutaneous pulmonary valve implantation (PPVI): Two-years follow-up by

cardiac magnetic resonance (CMR) E.C. Resta, San Donato Milanese /IT

14:30 – 15:45 CASE DISCUSSION 1 ROOM 3

Level 1-2 Aortic valve disease and TAVI Chair: U. Kramer, Tuebingen/DE

R. Salgado, Edegem/BE 14:30 151 Case 1 L. Lehmkuhl, Leipzig/DE

14:50 152 Case 2 R. Salgado, Edegem/BE 15:10 154 Case 3 E. Vermes, Tours/FR 15:30 Discussion 16:00 – 16:30 INDUSTRY-SPONSORED SYMPOSIUM ROOM 1

Low kV imaging in cardiovascular computed tomography using high concentrated contrast material Chair: A. Blum, Nancy/FR

16:00 Th. Henzler, Mannheim/DE

16:00 – 17:15 STATE OF THE ART LECTURES 4 ROOM 2

Level 2-3 Quantitative imaging of myocardial perfusion Chair: N. Kachenoura, Paris/FR R. Rienmueller, Graz/AT 16:00 155 Fractional flow reserve using CT: Review V. Sinitsyn, Moscow/RU 16:15 156 Protocols and results of CT perfusion K. Nikolaou, Munich/DE 16:30 157 Quantitative methods without contrast medium injection in cardiac MR

F. Kober, Marseille/FR 16:45 158 Quantisation and parametric mapping of CT and MR perfusion N. Kachenoura, Paris/FR 17:00 Discussion

16:00 – 17:15 HIGHLIGHTED LECTURES 2 ROOM 3

Level 2-3 The thoracic aorta from physiopathology to guidelines Chair: K.F. Kreitner, Mainz/DE J.M. Serfaty, Nantes/FR 16:00 159 Aortic stiffness and MRI A. Redheuil, Paris/FR 16:15 160 Wall, thrombi and plaque characterisation of the thoracic aorta in CT and

cardiac MR T. Saam, Munich/DE

16:30 161 Acute aortic diseases in CT or cardiac MR Ch. Loewe, Vienna/AT 16:45 162 How to estimate dilatation of the thoracic aorta: We need guidelines E. Mousseaux, Paris/FR 17:00 Discussion 17:30 - 18:30 ESCR meets AUSTRIA ROOM 1

Level 2-3 Cardiac imaging in the heart of Europe Chair: Ch. Loewe, Vienna/AT K. Gruszczynska, Katowice/PL 17:30 163 Austrian lifestyle: When speed doesn’t matter Ch. Loewe, Vienna/AT 17:45 164 Austrian lifestyle: When speed does matter F. Wolf, Vienna/AT 18:00 165 Austria: Country of rocks and rocky motion G. Feuchtner, Innsbruck/AT 18:15 Discussion


Calcium scoring and coronary plaque imaging Chair: Ch. Peebles, Southampton/UK R. Rienmueller, Graz/AT

17:30 166 Multislice computed tomography in the morphological evaluation of atherosclerotic plaques in the coronary arteries of patients with non-ST elevation acute coronary syndrome

S. Gaman, Moscow/RU 17:40 167 Association of high-sensitivity troponin T with atherosclerotic plaque

parameters derived by dedicated software S. Altintas, Maastricht/NL 17:50 168 Influence of motion on calcium scores in iterative reconstructed CT: A

multivendor dynamic phantom study M. Greuter, Groningen/NL

18:00 169 Overestimation of calcium scores in low dose CT: Influence of iterative

reconstruction M. Greuter, Groningen/NL 18:10 170 Calcium scoring on an anthropomorphic phantom at third generation dual-

source CT: What is the influence of the kV levels and iterative reconstruction on calcium score measurements?

G.J. Pelgrim, Groningen/NL 18:20 171 Assessing the pretest probability of obstructive coronary disease: Can we

afford to ignore the cardiovascular risk factors? A. Ferreira, Lisbon/PT 18:30 172 Are agatston scorese measured adequately at a large body size? A multi-

manufacturer study M. Willemink, Utrecht/NL 17:30 – 18:30 REFRESHER COURSE 4 ROOM 3

Level 2-3 Flow quantification in cardiac MR: Basic concepts and methodologies Chair: P. Gatehouse, London/UK J. Garcia Flores, Chicago/US 17:30 173 Basic concepts and methodologies of phase contrast imaging E. Mousseaux, Paris/FR 17:45 174 Quantification of velocities and flow rates: Accuracy and pitfalls P. Gatehouse, London/UK 18:00 175 Acceleration Fourier velocity encoding for 1D to 3D acquisition E. Durand, Kremlin-Bicetre/FR 18:15 Discussion

FRIDAY, OCTOBER 3, 2014 07:30 - 08:30 MORNING MEETING ROOM 3

With basic educational course on MR method 07:30 201 Black blood T1 and T2 weighted images J.N. Dacher, Rouen/FR 07:45 202 K space and SSFP acquisition: How to deal with L. Natale, Rome/IT 08:00 203 Perfusion imaging: Methods, plus tips and tricks Ch. Ritter, Wuerzburg/DE 08:15 204 Late gadolinium sequences and protocols A. Jacquier, Marseille/FR 08:30 - 09:45 HIGHLIGHTED LECTURES 3 ROOM 1

Level 2 Sudden death and cardiac imaging Chair: X. Jouven, Paris/FR R. Marano, Rome/IT 08:30 205 Epidemiology of sudden death X. Jouven, Paris/FR

08:45 206 Cardiac CT in primary prevention R. Marano, Frome/IT 09:00 207 Anomalous aortic origin of coronary arteries and sudden death: A critical

appraisal of risk J.P. Laissy, saint Denis Reunion/FR

09:15 208 Sudden death and imaging: The cardiologic point of view

A. Codreanu, Luxembourg/LX 09:30 Discussion 08:30 – 09:45 PROFFERED PAPER SESSION 4 ROOM 2

New insights into myocardium and coronaries Chair: P. Donato, Coimbra/PT R. Vliegenthart, Groningen/NL

08:30 209 Diagnostic performance of stress myocardial perfusion imaging compared to

fractional flow reserve: A meta-analysis R. Tax, Utrecht/NL 08:40 210 A preliminary study about the use of diffusion weighted images in the

evaluation of myocardial infarction: Our experience G. Benedetti, Milan/IT 08:50 211 Follow-up evaluation of myocardial strain in MitraClip patients using feature

tracking MRI and speckle tracking P. Krumm, Tuebingen/DE 09:00 212 Epicardial fat tissue in patients with diastolic LV dysfunction - CMR

quantification K. Gruszczynska, Katowice/PL

09:10 213 Evaluation of plaque characteristics in acute coronary syndromes by 64-MDCT

S. Gaman, Moscow/RU 09:20 214 Long-term prognostic value of dipyridamole stress CMR in patients with

known or suspected coronary artery disease G. Pontone, Milan/IT 09:30 215 Comparison of cardiac left-right performance in thalassemia major (TM) and

thalassemia intermedia (TI) patients using CMR: A myocardial T2* analysis F. Pitocco, Rome/IT


Level 2 Live anatomy-radiological session: A primer in congenital heart disease Chair: J.F. Paul, Le Plessis Robinson/FR Ch. Peebles, Southampton/UK 08:30 216 Normal anatomy: LV, mitral and aortic valve L. Houyel, Le Plessis Robinson/FR J.F. Paul, Le Plessis Robinson/FR 08:45 217 Normal anatomy: RV, tricuspid and pulmonary valve L. Houyel, Le Plessis Robinson/FR Ch. Peebles, Southampton/UK 09:00 218 Ebstein abnormities L. Houyel, Le Plessis Robinson/FR Ch. Peebles, Southampton/UK

09:15 219 Atrial septal defects L. Houyel, Le Plessis Robinson/FR J.F. Paul, Le Plessis Robinson/FR 09:30 Discussion 10:00 - 11:30 HIGHLIGHTED LECTURES 4 ROOM 1

Level 3 Sudden death: Substrates of arrhythmia and imaging Chair: D. Bluemke, Bethesda/US E. Di Cesare, L’Aquila/IT 10:00 220 Substrate of cardiac arrhythmia at histology

P. Bruneval, Paris/FR

10:20 221 Fibrosis in CT and MR N. Mewton, Lyon/FR 10:40 222 Unrecognized myocardial infarct and sudden death: What we know J. Bogaert, Leuven/BE 11:00 223 Imaging and substrate of arrhythmias in acute MI P. Croisille, Lyon/FR 11:20 Discussion 10:00 – 11:30 EPOS HIGHLIGHTED LECTURES ROOM 2

Chair: J.M. Serfaty, Nantes/FR R. Rienmueller, Graz/AT 10:00 401 Factors influencing the direction of blood flow inside the left ventricle

M. Karvandi, Tehran/IR 10:05 402 Nonatherosclerotic Coronary Vasculitis: Assessment with Cardiac MDCT

J.Kim, Gyeonggido/KR 10:10 403 Effect of different reconstruction algorithms on quantitative

evaluation of dynamic CT data for the estimation of myocardial blood flow T.Rienmüller, Hall in Tirol/AT

10:15 404 Atrial delayed enhancement MRI: clinical correlates in patients with and without atrial fibrillation

G.Chevreau, Pessac/FR 10:20 405 Atrial outcome 5 years after Successful Ablation for Persistent Atrial Fibrillation: an MRI Study

H.Nivet, Pessac/FR 10:25 406 Quantification of right ventricular fat from MDCT images: diagnostic performance performance in arrythmogenic right ventricular cardiomyopathy

T.Ait Ali, Pessac/FR 10:30 407 Quantification of right ventricular fat from MDCT images: electrical characterization in arrhythmogenic right ventricular cardiomyopathy

T.Ait Ali, Pessac/FR 10:35 408 A novel mathematical based software for modeling the left ventricular

myocardium M. Karvandi, Tehran/IR

10:40 409 Real-time image integration during cardiac ablation for post infarction ventricular tachycardia: impact on clinical outcome

M.Salel, Vigoulet-Auzil/FR

10:45 410 Cushing’s syndrome: myocardial tissue characterization by CMR C.Roux, Paris/FR

10:50 411 Geometric differences between end-systolic and end-diastolic phases of the right coronary artery on CT angiography

J. van Zandwijk, Groningen/NL 10:55 412 Achievability of the assessment of the mitral valve leaflets by mathematical equations of inelasticity based on echocardiography

S.Ranjbar, Tehran/IR 11:00 413 Uncommon and atypical cardiovascular calcifications

D. Varona Porres, Barcelona/ES 11:05 414 Myocardial inflammation on Cardiac Magnetic Resonance at diagnosis of pediatric dilated cardiomyopathy predicts outcome

F.Raimondi, Paris/FR 11:10 415 Prognostic CMR parameters for heart failure and arrhythmias in large cohort of well treated thalassemia major patients

C.Tudisca, Palermo/IT 11:15 416 Comparative assessment of thoracic aortic aneurysms by trans-thoracic echocardiography versus computerized tomography

M.Amsallem, Paris/FR 11:20 Poster Awards


Level 2 Cross-sectional imaging in GUCH patients Chair: L. Iserin, Paris/FR Ch. Peebles, Southampton/UK 10:00 224 Multidisciplinary approach in GUCH patients L. Iserin, Paris/FR 10:15 225 Role of CT and MR in Fallot disease G. Soulat, Paris/FR 10:30 226 MR in systemic right ventricle M. Ladouceur, Paris/FR 10:45 227 CT and MR after arterial switch M. Gutberlet, Leipzig/DE

11:00 228 CT and MR in single ventricle L. Bousel, Lyon/FR 11:15 Panel discussion 11:45 - 12:45 INDUSTRY-SPONSORED SYMPOSIUM ROOM 1

Innovations in the field of cardiac CT imaging: What’s new? 13:00 - 14:15 HIGHLIGHTED LECTURES 5 ROOM 1

Level 2 Sudden death and cardiac imaging: The right ventricle Chair: Ch. Loewe, Vienna/AT S. Babu-Narayan, London/UK 13:00 229 Imaging the right ventricle by CT and cardiac MR K.F. Kreitner, Mainz/DE 13:15 230 Arrythmogenic right ventricular dysplasia: Role of MR L. Natale, Rome/IT 13:30 231 Arrythmogenic right ventricular dysplasia: Role of CT H. Cochet, Pessac/FR 13:45 232 MR in the arrythmogenic right ventricle of congenital heart disease S. Babu-Narayan, London/UK 14:00 Discussion 13:00 – 14:15 EXPERIMENTAL RESEARCH SESSION ROOM 2

Level 3 Small animals and cardiovascular MR: Methodological aspects and illustration of experimental works

Chair: F. Kober, Marseille/FR A. Eposito, Milan/IT 13:00 233 MR relaxometry and function of the LV in rats Ph. Ou, Paris/FR Ph. Garteiser, Paris/FR 13:15 234 Perfusion of the myocardium in rats F. Kober, Marseille/FR 13:30 235 Imaging of unstable atherosclerotic plaques: Learning from animals A. Esposito, Milan/IT

13:45 236 Structural substrate of cardiac arrhythmia: What can we learn from

animals? O. Bernus, Bordeaux/FR

14:00 Discussion


Level 2-3 My most difficult cases Chair: A. Madureira, Porto/PT K. Gruszczynska, Katowice/PL 13:00 237 Case 1 P. Donato, Coimbra/PT 13:15 238 Case 2 F. De Cobelli, Milan/IT 13:30 239 Case 3: True or false LV aneurysm K. Gruszczynska, Katowice/PL 13:45 240 Cases about common mistakes/pitfalls made in reading cardiac MR studies S.C.W. Cheung, Hong Kong/CN 14:00 Discussion 14:30 - 15:45 HIGHLIGHTED LECTURES 6 ROOM 1

Level 2 Sudden death and cardiac imaging: The left ventricle at CT or MR Chair: E. Mershina, Moscow/RU A. Hagege, Paris/FR 14:30 241 Hypertrophic CM and sudden death F. De Cobelli, Milan/IT 14:45 242 Dilated CM and sudden death A. Jacquier, Marseille/FR 15:00 243 CT and/or cardiac MR for ICD planning implantation R. Salgado, Edegem/BE 15:15 244 Role of imaging to guide catheter ablation therapy H. Cochet, Pessac/FR 15:30 Discussion 14:30 – 15:45 PROFFERED PAPER SESSION 5 ROOM 2

Arrythmias and atrial evaluation Chair: J.M. Serfaty, Nantes/FR R. Budde, Utrecht/NL 14:30 245 Myocardial substrate of recurrent ventricular tachycardia: Relationship

between late-enhancement multidetector computed tomography (MDCT-LE) and electroanatomic mapping

A. Palmisano, Milan/IT 14:40 246 Structure-function relationships in 92 consecutive patients referred for scar-

related VT ablation with real-time image integration M. Salel, Vigoulet-Auzeil/FR 14:50 247 Evaluation of atrial structural remodeling with LGE MRI

O. Aparina, Moscow/RU 15:00 248 Atrial delayed enhancement MRI: Electrical characterization in persistent

atrial fibrillation G. Chevreau, Pessac/FR 15:10 249 Magnetic resonance angiography with esophagus intensification to assess

anatomic relationship of the esophagus and left atrium R. Faletti, Turin/IT 15:20 250 Cardiac computed tomography versus cardiac magnetic resonance for

characterisation of left atrium anatomy before radiofrequency catheter ablation of atrial fibrillation

G. Pontone, Milan/IT 15:30 251 The role of post-procedure MRI to predict pulmonary vein reconnection

following atrial fibrillation ablation

H. Nivet, Pessac/FR


Cardiac MR flow in GUCH using CT or cardiac MR Chair: I. Mastorakou, Athens/GR 14:30 252 Cardiac MR in cardiac shunt K. Warin-Fresse, Nantes/FR 14:45 253 Cardiac MR in coarctation

N. Kelekis, Athens/GR 15:00 254 Case 1: Abnormal venous return J. Glowacki, Zabrze/PL

15:15 255 Case 2: CMR in evaluation GVT (TGA) after Rastelli procedure

K. Genova, Sofia/BG 15:30 Discussion 16:00 – 17:00 INDUSTRY-SPONSORED SYMPOSIUM ROOM 1

Anatomy meets function: FFRCT for diagnosis of CAD Chair: M. Gutberlet, Leipzig/DE 16:00 Welcome and introduction M. Gutberlet, Leipzig/DE 16:05 Invasive FFR – the gold standard M. Gilard, Brest/FR 16:15 FFRCT: How does it work? Th. Bley, Wuerzburg/DE 16:30 Personal experience using FFRCT in clinical practice G. Pontone, Milan/IT 16:40 Q&A with panel discussion M. Gutberlet, Leipzig/DE 16:50 Summary and key take-aways M. Gutberlet, Leipzig/DE 16:00 – 17:15 CASE DISCUSSION 4 ROOM 2

Level 2 Differential diagnosis of cardiomyopathies Chair: A. Jacquier, Marseille/FR 16:00 256 Case 1: HCM vs. myocardium of top athlete B.K. Velthuis, Utrecht/NL 16:15 257 Case 2: Dilated CM vs. normal heart A. Jacquier, Marseille/FR 16:30 258 Case 3: Pitfall in diagnosis of HCM A. Madureira, Porto/PT 16:45 259 Case 4: Amyloidosis versus hypertrophic LV J.F. Deux, Creteil/FR

17:00 Discussion

16:00 – 17:15 HIGHLIGHTED LECTURES 7 ROOM 3

Level 2 Sudden death and myocardial inflammation at CT or MR Chair: O. Vignaux, Paris/FR M. Francone, Rome/IT 16:00 260 Sarcoidosis O. Vignaux, Paris/FR

16:15 261 How to estimate oedema in cardiac MR? D. Mandry, Nancy/FR 16:30 262 Diagnosis of myocarditis by using cardiac MR: Is there a consensus? M. Francone, Rome/IT 16:45 263 Cardiac MR and Tako-Tsubo K.F. Kreitner, Mainz/DE 17:00 Discussion 17:30 – 18:30 ESCR MEETS NASCI ROOM 1

Level 2 New technique in imaging CAD Chair: R. Vliegenthart, Groningen/NL U.J. Schoepf, Charleston/US

17:30 264 Myocardial perfusion CT U.J. Schoepf, Charleston/US 17:45 265 Integration of non-invasive imaging in practice: The RESCUE trial A. Stillman, Atlanta/US 18:00 266 Prognostic value of cardiac MRI findings in asymptomatic population: the

MESA study D. Bluemke, Bethesda/US 17:30 – 18:30 STUDENT SESSION ROOM 2

Chair: J. Bremerich, Basle/CH R. Saru, Rotterdam/NL 17:30 267 Meaning and definition of relative hypo perfusion, myocardial thinking,

kinesis grading, contractile reserve and recovery J. Bremerich, Basle/CH 17:40 268 Impact of left ventricular myocardial infarction on right ventricular function

and remodeling: CMR study X. Stefanovic, Montpellier/FR 17:50 269 Multidetector computer tomography in determining sinoatrial nodal artery M. Shlyappo, Moscow/RU 18:00 270 CMR evaluation of diastolic function impairment in Cushing’s syndrome and

its normalization with treatment Ch. Roux, Paris/FR 18:10 271 The impression, expectations, suggestions and preferences for improvement

of preclinical medicine students in the field of radiology and cardiac radiology

R. Gueney, Giresun/TR 18:20 272 Estimation of left ventricular ejection fraction in chronic heart disease on

cardiac MRI: parameters responsible for an increased inter-observer variability

Th. Giraudmaillet, Toulouse/FR 17:30 – 18:30 STATE OF THE ART LECTURES 5 ROOM 3

Level 3 Cardiac MR flow and other tools to study diastolic function Chair: G. Pontone, Milan/IT A. de Roos, Leiden/NL

17:30 273 Physiopathology of the diastolic dysfunction D. Pellerin, London/UK 17:45 274 The role of Echo to study the diastolic function Tbc. 18:00 275 The role of MR to study the diastolic function Ph. Germain, Strasbourg/FR 18:15 Discussion: Is it only a job for Echo? SATURDAY, OCTOBER 4, 2014

07:30 - 08:30 MORNING MEETING ROOM 3

With advanced educational course on MR method 07:30 301 T1 Mapping Ch. Luecke, Leipzig/DE 07:45 302 T2 mapping and T2* M. Viallon, Lyon/FR 08:00 303 Real time imaging A. Weng, Wuerzburg/DE 08:15 304 Parallel imaging in cardiac radiology G. Sommer, Basle/CH 08:30 – 09:45 HIGHLIGHTED LECTURES 8 ROOM 1

Level 2 Cardiometabolic disease: Part 1 Chair: K. Clement, Paris/FR D. Hahn, Kuernach/DE 08:30 305 Cardiometabolic disease: What can we expect from imaging K. Clement, Paris/FR 08:45 306 Fat imaging techniques in cardiometabolic diseases A. De Roos, Leiden/NL 09:00 307 Preventing and detecting ischemic heart disease in obese subjects by

cardiac imaging A. Redheuil, Paris/FR 09:15 308 CT and subclinical coronary atherosclerosis in patients with familial

hypercholesterolemia P.J. De Feyter, Rotterdam/NL 09:30 Discussion

08:30 – 09:45 STATE OF THE ART LECTURES 6 ROOM 2

Level 2-3 Hypertrophic cardiomyopathies at cardiac MR Chair: R. Marano, Rome/IT M. Gutberlet, Leipzig/DE 08:30 309 HCM B.J. Wintersperger, Toronto/CA

08:45 310 Fabry diseases M. Beer, Ulm/DE 09:00 311 Amyloidosis J.F. Deux, Creteil/FR 09:15 312 How to deal with the origin of an hypertrophic cardiomyopathy? V.O. Puntmann, London/UK 09:30 Discussion


Level 2-3 Myocardial stress imaging with cardiac MR Chair: R. Bury, Blackpool/UK D. Revel, Lyon/FR

08:30 313 Stress imaging: Drugs and physiopathological concepts M. Rees, Gwynedd/UK 08:45 314 Assessment of coronary artery stenosis severity with adenosine stress E. Nagel, London/UK 09:00 315 The concept of myocardial viability: Dead or still alive at cardiac MR? D. Revel, Lyon/FR 09:15 316 Stress imaging in patients with symptomatic patients with known ACD:

What is the best strategy? A. Furber, Angers/FR 09:30 Discussion 10:00 - 11:30 HIGHLIGHTED LECTURES 9 ROOM 1

Level 2 Cardiometabolic disease: Part 2 Chair: M. Rees, Gwynedd/UK P. Valensi, Bondy/FR 10:00 317 CAD detection and revascularization in diabetic subjects: What is

recommended P. Valensi, Bondy/FR 10:20 318 CT in evaluating CAD risk in diabetic subjects Ph. Douek,Lyon/FR 10:40 319 The diabetic cardiomyopathy: What we learned from cardiac MR

H.J. Lamb, Leiden/NL

11:00 320 Cardiac imaging in patients with T1 diabetes: The EDIC study D. Bluemke, Bethesda/US 11:20 Discussion

10:00 – 11:30 EUROPEAN RESEARCH NETWORK in CARDIAC IMAGING ROOM 2

Level 3 How to obtain funding for your next great idea in CV imaging Chair: N. Kachenoura, Paris/FR Chair: T. Leiner, Utrecht/NL 10:00 321 How to design and set up a diagnostic study in CV imaging G. Chatellier, Paris/FR

10:15 322 Funding opportunities in HORIZON 2020 – European Union’s Research and Innovation programme V. Dambrauskaite, Brussels/BE

10:30 323 The real world: My experience with obtaining European funding for the Robinsca Trial M. Oudkerk, Groningen/NL

10:45 Research in cardiac imaging by five representatives of European countries

11:10 Discussion 10:00 – 11:30 REFRESHER COURSE 8 ROOM 3

Level 2-3 CT and cardiac MR including flow imaging for aortic valve diseases Chair: G. Feuchtner, Innsbruck/AT J.M. Serfaty, Nantes/FR

10:00 324 Effective versus geometric orifice areas in aortic valve stenosis: Can we use planimetry in cardiac imaging? J. Garcia Flores, Chicago/US 10:20 325 Cardiac MR in aortic valve stenosis J.M. Serfaty, Nantes/FR 10:40 326 Cardiac MR in aortic valve regurgitation Ph. Ou, Paris/FR 11:00 327 CT in aortic valve diseases (TAVI excluded) G. Soulat, Paris/FR 11:20 Discussion

11:40 - 12:00 INDUSTRY-SPONSORED SYMPOSIUM ROOM 1

13:00 - 14:15 HIGLIGHTED LECTURES 10 ROOM 1

Level 2 CT and cardiac MR in valve diseases: Can we go further? Chair: A. Jacquier, Paris/FR E. Mershina, Moscow/RU 13:00 328 CT & cardiac MR in mitral and tricuspid valve diseases G. Pontone, Milan/IT 13:15 329 When can we avoid a coronary angiography before valve surgery by using CT? L. Lehmkuhl, Leipzig/DE 13:30 330 CT in endocarditis

G. Feuchtner, Innsbruck/AT 13:45 331 CT in prosthetic heart valve disease R. Budde, Utrecht/NL 14:00 Discussion


Myocarditis and cardiomyocarditis Chair: A. Furber, Angers/FR

K. Gruszczynska, Katowice/PL 13:00 332 Interobserver variability of myocardial T1 and T2 mapping in patients with

suspected myocarditis Ch. Luecke, Leipzig/DE 13:10 333 Potential role of T1 and T2 mapping sequences in the diagnosis of acute

myocarditis A. Rahmouni, Creteil/FR 13:20 334 Magnetic resonance in myocarditis: Who and when? M. Gatti, Turin/IT 13:30 335 Prognostic role of cardiac magnetic resonance (CMR) in patients with acute

myocarditis as regards to the symptoms M. Cava, Milan/IT 13:40 336 Myocardial T1-mapping and T1-derived extracellular volume fraction (ECV)

in patients with chronic HIV-infection C. Naehle, Bonn/DE 13:50 337 Global longitudinal strain predicts death by heart failure in hypertrophic

cardiomyopathy P. Reant, Bordeaux/FR 14:00 338 Potential role of mapping T1 and T2 sequences in the diagnosis of cardiac

amyloidosis F. Ridouani, Paris/FR


Level 3 Imaging in ventricular arrhythmia, dyssynchrony and ventricular assist devices Chair: B. Diebold, Paris/FR

R. Salgado, Edegem/BE 13:00 339 Clinical and echocardiography issues and treatment options B. Diebold, Paris/FR 13:15 340 CT and/or cardiac MR for planning of cardiac resynchronization therapy L. Natale, Rome/IT 13:30 341 Cardiac imaging for planning ventricular assist devices D. Mandry, Nancy/PL 13:45 342 Cardiac imaging after planning ventricular assist devices A. Azarine, Paris/FR 14:00 Discussion

14:15 – 15:15 INDUSTRY-SPONSORED SYMPOSIUM ROOM 1

14:15 – 15:15 ESCR MEETS ASCI ROOM 2

Level 2-3 CT in coronary artery imaging Chair: J. Hoe, Singapore/SG M. Gutberlet, Leipzig/DE 14:15 343 Avoiding misinterpretation in coronary CTA J. Hoe, Singapore/SG

14:30 344 Plaque characterisation in coronary arteries M. Jinzaki, Tokyo/JP 14:45 345 Prognostic value of coronary CT angiography versus calcium score in

outpatients B. Lu, Beijing/CN 15:00 Discussion 14:15 – 15:15 CASE DISCUSSION 5 ROOM 3

Level 2 Stress perfusion in cardiac MR or CT Chair: T.H. Kim, Seoul/KR P. Croisille, Lyon/FR 14:15 346 Case 1

A. Chiribiri, London/UK 14:35 347 Case 2: Adenosine stress perfusion MR – CAD and beyond D. Piotrowska-Kownacka, Warsaw/PL 14:55 348 Case 3: Pitfalls in reading CT myocardial rest and stress perfusion studies T.H. Kim, Seoul/KR

15:45 – 16:45 ESCR MEETS ESTI ROOM 1

Level 2 Pulmonary artery hypertension: Guidelines, CT and MR Chair: C. Schaefer-Prokop, Vienna/AT J. Bremerich, Basel/CH 15:45 349 Imaging and right catheterisation in guidelines S. Guenther, Le Kremlin Bicetre/FR 16:00 350 RV function assessment by using CT and MR in PA hypertension F. Pontana, Lille/FR 16:15 351 Pulmonary artery hemodynamics by using MR flow U. Reiter, Graz/AT 16:30 Discussion

15:45 - 16:45 RESEARCH SESSION ROOM 2

Level 2-3 New techniques in myocardial perfusion CT: Are we there yet? Chair: Y.H. Choe, Seoul/KR 15:45 352 Overview of current myocardial perfusion imaging techniques M. Oudkerk, Groningen/NL 16:00 353 A role of dual-energy CT?

Th. Henzler, Mannheim/DE 16:15 354 Do we need dynamic CT perfusion or is snapshot imaging sufficient? R. Vliegenthart, Groningen/NL 16:30 Discussion


Level 2 Mitral and tricuspid valve diseases Chair: A. Azarine, Paris/FR

B. Lu, Beijing/CN 15:45 355 Case 1 and 2: Mitral valve disease and CT A. Azarine, Paris/FR 16:05 356 Case 3: Ebsteins anomaly vs. ARVD Ch. Peebles, Southampton/UK 16:25 357 Case 4: Mitral valve regurgitation and cardiac MR A. Hidalgo, Barcelona/ES

17:00 - 18:00 CLOSING SESSION ROOM 1

Level 2-3 New technologies for the future Chair: Ch. Loewe, Vienna/AT E. Mousseaux, Paris/FR

17:00 358 Myocardial spectroscopy and other metabolic biomarkers M. Beer, Ulm/DE 17:20 359 Fusion between ECG mapping (rotor) and CT/MR imaging P. Jais, Bordeaux/FR 17:40 360 4D flow imaging in cardiac MR J. Garcia Flores, Chicago/US

thursday, october 2, 2014 08:30 09:45 state of … · 2014-09-26 · level 2 coronary artery...

Documents